Calls for free sunscreen amid rising skin cancer rates in Ireland and Britain
Councillors warn that, without swift action, the number of melanoma cases in Ireland could more than double by 2045.
The motion, brought forward by Fine Gael councillor Aileen Browne, draws on data from the National Skin Cancer Prevention Plan 2023–2026.
It points to Ireland's unique circumstances due to the high prevalence of fair skin and increased UV exposure, even with typically overcast Irish weather.
'People often assume sunscreen is only necessary in hot climates, but that's a dangerous misconception,' Browne said in a statement.
'UV rays don't take a holiday just because the sun isn't shining. This is not just a seasonal issue; it's a pressing public health concern.'
The proposal, which won cross-party backing, suggests setting up sunscreen dispensers in schools, libraries and other public areas.
It's modelled on the hand sanitiser stations during the COVID pandemic and is being presented as a cost-effective preventative measure.
Treating advanced melanoma can cost the Irish state over €122,000 per case, while prevention and early-stage intervention require a lot less money.
'This is about saving lives and relieving pressure on our already overburdened health system,' she added.
Independent councillor Ben Dalton-O'Sullivan referenced the HSE's 2023 pilot project that installed a public sunscreen dispenser at Fountainstown Beach in Cork.
He's now calling for that initiative to be rolled out across all coastal areas in the county.
For Irish families living in Britain, where melanoma rates are also rising, the council's actions in Cork could be a model to emulate.
The NHS doesn't currently offer free sunscreen, even though skin cancer is the most common form of cancer in Britain.
According to Cancer Research UK, cases of melanoma have more than doubled since the early 1990s, with Irish communities considered high-risk.
Councillors in Cork are now appealing to Health Minister Jennifer Carroll MacNeill to adopt the initiative nationally.
'This is a simple, effective step we can take now,' Browne said. 'The longer we wait, the higher the cost, in lives and in euros.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Journal
2 hours ago
- The Journal
HSE has helped just 104 younger people move out of nursing homes for the elderly
THE HSE'S PROGRAMME to help younger people transition out of nursing homes has helped just 104 people move into alternative settings, with hundreds more left languishing in care homes designed for older people. Efforts to reduce the cohort of people aged under 65 living in nursing homes are facing obstacles as the HSE has said that after an initial decrease, the numbers have now 'plateaued'. There are still 1,227 people aged under 65 living in nursing homes for older people according to HSE figures given in July of this year. The programme to help younger people move out of nursing homes was set up in response to the 2021 Wasted Lives report by the Ombudsman, which found serious problems in how they were being treated. A team that tracked the issue within the HSE in 2023 found the main reason for people under 65 entering nursing homes that year was due to referrals from acute healthcare settings, typically a hospital. This led to 136 people being placed in nursing homes that year. The next biggest reason was the lack of an alternative appropriate placement (135 cases). Family circumstances, referral from community services, and a lack of a primary carer were other factors that the team found. For 32 cases that year, the reason for the younger being entered into the care of a nursing home was only recorded as 'unknown'. Acquired brain injury is the primary diagnosis for more than one quarter (26%) of all younger people living in a nursing home, according to data provided by an operational tracker which looks at younger people in nursing homes. This is followed by acquired neurological conditions, such as multiple sclerosis, which account for 24% of people in this group. Other people have conditions including cerebral palsy and spina bifida, or in some cases an intellectual disability. Social Democrats TD Liam Quaide, who requested these figures from the HSE, said that the process of transferring younger people out of inappropriate nursing home settings is 'frustratingly slow'. 'This is a desperately sad and indefensible situation. It is another example of how much distance is opening up between our economic prosperity, on the one hand, and the vindication of disabled people's basic rights, on the other. 'Perpetuating younger people's reliance on nursing homes is an affront to their dignity and right to independence,' Quaide said. The Social Democrats TD said that nursing homes are also being used for temporary care for people awaiting a placement in the National Rehabilitation Hospital. Advertisement He pointed out that four years have now passed since the publication of the Wasted Lives report. That initial report was sparked by the Ombudsman receiving a number of complaints from people under 65 who were living in nursing homes at that time. The office carried out 28 visits to people affected by the issue. It found that Ireland has a long way to go in terms of moving from a medical to a social model of disability. As of 30 June 2020 there were some 1,320 people under 65 being supported by the Nursing Homes Support Scheme (the Fair Deal scheme) according to HSE figures. Slow pace of transition In response to the report the HSE set up its U65 Programme Office and an Implementation Project Team. There is an 'U65′ lead in each Community Healthcare Organisation who is responsible for people transitioning to other care settings. Since this work began there have been a total of 104 transitions. The majority of these people have moved to community residential placements including sheltered living, specialised and residential placements, to their own home or family home, or to a new home. It is expected that 17 other people will transfer out of nursing homes before the end of 2025. The HSE said that people who need to stay in nursing homes can avail of enhanced quality of life supports funded by the U65 programme which include access to personal devices, transport, social care, and vocational and therapeutic services, as well as personal assistant hours. However the number of people availing of these supports are very low. In 2024 just 154 of the people who are under 65 living in nursing homes availed of the supports package. The HSE said that there was a decrease in this age group residing in nursing homes between 2021 and 2023, when there was a decrease of around 100 people, but since then the average number of under-65s in nursing homes per month has 'plateaued' to an average of 1,250 people. The HSE's programme provides funding to help people in this cohort transfer to other settings, and the average cost of these transfers is €207,926. The HSE has said that the primary reason why younger people are staying in nursing homes is due to their personal will and preference. 'Disability services recognise that the issue of will and preference is changeable and that there needs to be planned engagements with individuals to better understand their reasons why they may wish to stay,' a spokesperson said. Readers like you are keeping these stories free for everyone... A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation. Learn More Support The Journal
Irish Independent
5 hours ago
- Irish Independent
Cork fish kill in River Blackwater not caused by discharge from EPA-licensed sites, samples suggest
The EPA received a report on August 12 of dead fish in the River Blackwater and Clyda River in the Mallow area. The agency inspected EPA-licensed industrial sites and urban wastewater discharged in the area on the same day the report was lodged. A spokesperson for the EPA told The Corkman that preliminary reports indicate normal water quality in the area. 'While the investigation is ongoing, preliminary sample results indicate no causal link between the fish kill and discharges from EPA-licensed sites. 'The preliminary results from river water samples taken by EPA and Cork County Council indicate normal water quality in the area,' the spokesperson said. The EPA will continue to liaise with Cork County Council and Inland Fisheries Ireland, which is investigating the cause of the fish kill. A spokesperson for Cork County Council stressed to The Corkman that the exact cause for the fish kill has not been confirmed. 'We understand investigations to date have determined no evidence of water pollution. 'It is thought a fungal infection may be responsible; however, it is important to stress that the exact cause is unknown at this stage. 'Water quality assessments and investigations are ongoing,' the spokesperson said. An IFI spokesperson told The Corkman on Friday that more than 2,000 fish had died in a 16km stretch of the River Blackwater, but a statement released by the state body on Monday suggests the number is now in between 8,000 to 10,000 mortalities. Sean Long, Director of IFI's South-Western River Basin District, said The Marine Institute conducted diagnostic sampling of affected fish on site on August 14 at Mallow. 'IFI expects to receive a related report within 20 days of that date. 'Disease outbreaks can occur in wild fish populations and are influenced by numerous factors including environmental change. 'No evidence of a polluting or harmful discharge has been detected to date in the river,' he said. IFI continues to consult with Uisce Éireann, the EPA, Cork County Council and the Marine Institute on the matter. The Marine Institute's Fish Health Unit has advised the removal of dead fish from the water is not necessary. Affected trout were observed in the River Blackwater approximately six kilometres downstream of Mallow, and up to 12 kilometres upstream of Mallow. They have also been seen at the Awbeg river, and the Clyda river-which joins the Blackwater west of Mallow. IFI continues to appeal to people to report instances of fish kills to its 24-hour confidential phoneline, 0818 34 74 24.
Irish Independent
6 hours ago
- Irish Independent
Profits at Novartis Ireland down to €8.4m as firm raises research and development spend
New accounts filed by Novartis Ireland Ltd show the company recorded the drop in pre-tax profits as revenues declined by 10pc from €268.3m to €242.3m. Novartis Ireland is a significant employer in the healthcare industry here with over 1,000 employed in Dublin. Accounts show revenues from the sale of goods declined from €139.86m to €137.55m while revenues from supply of business services decreased from €128.46m to €104.77m. The directors state that revenues declining in pharma products sales were due to price and volume erosion of mature products. Turnover relating to Novartis Corporate Centre (NOCC) services decreased by 18pc driven primarily by the reduction in functions related to Novartis's global initiative which launched in 2022 targeting a more focused pharmaceutical offering. The company has a significant R&D arm in Ireland with numbers employed last year increasing from 224 to 270. Last year, Novartis Ireland increased R&D spend from €26.4m to €34.9m. And the company booked an R&D credit of €4.5m in the profit and loss account. Overall numbers employed at Novartis Ireland Ltd reduced from 1,024 to 1,010 last year. The company employed 663 in 'general and administration', 72 in marketing, sales and distribution and five in production and supply. ADVERTISEMENT Staff costs last year declined from €138.8m to €123.98m, that included €95.5m in wages and salaries and €4.7m in share-based payments. Directors' pay increased from €992,000 to €1.35m made up of €1.27m in emoluments and €76,000 in pension contributions. During the year, the company launched two new medicines aimed at treating cancer, Luxturna and Leqvio. Under the heading of patient expiration and product competition, the directors state that 'the Irish Government continues to closely monitor pharmaceutical pricing and profitability, with pressure to control spending on HSE medicines'. Shareholder funds totalled €88.8m, that included accumulated profits of €51.9m.
